Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 2,005 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 2,005 shares of the stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $6.11, for a total value of $12,250.55. Following the transaction, the insider now owns 126,226 shares in the company, valued at $771,240.86. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Health Catalyst Price Performance

Shares of HCAT stock opened at $5.58 on Friday. Health Catalyst, Inc. has a fifty-two week low of $5.51 and a fifty-two week high of $14.37. The business’s 50 day moving average price is $7.80 and its 200-day moving average price is $8.41. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.06. The firm had revenue of $75.08 million for the quarter, compared to analyst estimates of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. On average, sell-side analysts forecast that Health Catalyst, Inc. will post -0.47 EPS for the current year.

Institutional Investors Weigh In On Health Catalyst

Several hedge funds have recently made changes to their positions in the company. The Manufacturers Life Insurance Company boosted its position in shares of Health Catalyst by 3.8% during the fourth quarter. The Manufacturers Life Insurance Company now owns 22,016 shares of the company’s stock valued at $234,000 after purchasing an additional 796 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Health Catalyst by 2.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 39,757 shares of the company’s stock valued at $464,000 after purchasing an additional 970 shares in the last quarter. Fairfield Bush & CO. bought a new stake in shares of Health Catalyst during the first quarter valued at approximately $25,000. Panagora Asset Management Inc. boosted its position in shares of Health Catalyst by 3.0% during the first quarter. Panagora Asset Management Inc. now owns 36,670 shares of the company’s stock valued at $428,000 after purchasing an additional 1,079 shares in the last quarter. Finally, US Bancorp DE boosted its position in shares of Health Catalyst by 14.0% during the first quarter. US Bancorp DE now owns 9,260 shares of the company’s stock valued at $242,000 after purchasing an additional 1,139 shares in the last quarter. 85.00% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Evercore ISI reduced their price objective on Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Cantor Fitzgerald restated an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research report on Wednesday, April 10th. Guggenheim upgraded Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price target on the stock in a research report on Friday, January 26th. Piper Sandler restated an “overweight” rating and set a $15.00 price target (down from $17.00) on shares of Health Catalyst in a research report on Friday, February 23rd. Finally, KeyCorp restated a “sector weight” rating on shares of Health Catalyst in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Health Catalyst presently has a consensus rating of “Moderate Buy” and an average price target of $12.10.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.